2 results
Approved WMOCompleted
The primary objective of this trial is to evaluate and describe the long-term safety of tolvaptan.
Approved WMOCompleted
To compare the efficacy of tolvaptan treatment in reducing the change in estimated glomerular filtration rate (eGFR) from pre-treatment baseline to post-treatment followup, as compared with placebo, in subjects with late-stage chronic kidney disease…